Transdermal laser associated with sclerotherapy in tumescent anesthesia for the treatment of telangiectatic matting

Telangiectatic matting refers to the proliferation of fine vessels with less than 0.2 mm diameter, often occurring as a secondary effect of sclerotherapy using hypertonic glucose or foam. It is one of the most aesthetically distressing and challenging complications of reticular vein and telangiectasia treatments, with spontaneous resolution reported between 3 to 12 months. The 1064-nm Nd:YAG transdermal laser holds a level 2b recommendation for treating matting, although various strategies have been explored due to the complexity of this condition. This case report presents the successful management of persistent matting using transdermal laser associated with sclerotherapy and tumescent anesthesia.